ERBA Diagnostics (ERBA) Stock Price, News & Analysis

Company Overview

Erba Diagnostics (OTCMKTS:ERBA) is a global provider of clinical diagnostic products and services, specializing in the development, manufacture and distribution of high-quality reagents, assays and instrumentation. The company serves a broad range of customers including hospital laboratories, research institutions, point-of-care settings and veterinary clinics. Its offerings span chemistry, immunochemistry, molecular diagnostics and microbiology, enabling healthcare professionals to conduct routine testing, disease screening and advanced biomarker analysis.

Founded in 1986 and headquartered in Mannheim, Germany, Erba Diagnostics has established manufacturing facilities and research centers in Europe and Asia. Over the years, the company has expanded its footprint through strategic partnerships and distribution agreements, reaching customers across Europe, the Middle East, Africa, South Asia and Latin America. This international presence supports both established and emerging markets, providing localized technical support and training services.

The company’s product portfolio includes a range of pre-analytical and analytical solutions such as reagent kits for clinical chemistry, enzyme immunoassays, nucleic acid amplification tests and antimicrobial susceptibility testing. Erba Diagnostics also offers a variety of fully automated and semi-automated analyzers, sample handling systems and laboratory software to streamline workflow, improve throughput and ensure data accuracy. Complementary services include instrument installation, calibration, maintenance and remote diagnostics support.

Erba Diagnostics places a strong emphasis on research and development, investing in the innovation of next-generation assays and automation technologies. Its leadership team, comprised of seasoned executives and scientific experts, focuses on expanding the company’s diagnostic capabilities through collaborative projects with academic institutions, industry partners and healthcare organizations. This commitment to quality and innovation underpins Erba Diagnostics’ goal of advancing patient care and laboratory efficiency worldwide.

Key Stats

• Today's Range: $0.04 to $0.04
• 50-Day Range: $0.04 to $0.04
• 52-Week Range: $0.01 to $0.31
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ERBA Stock Analysis - Frequently Asked Questions

How have ERBA shares performed this year?

ERBA Diagnostics' stock was trading at $0.0350 at the beginning of the year. Since then, ERBA shares have increased by 0.0% and is now trading at $0.0350.

How do I buy shares of ERBA Diagnostics?

Shares of ERBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ERBA Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ERBA Diagnostics investors own include EKF Diagnostics (EKF), Cannabis Wheaton Income (CBWTF), ContraFect (CFRX), Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN), iQIYI (IQ) and Myriad Genetics (MYGN).

Company Calendar

• Today: 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:ERBA
• Previous Symbol: NYSEMKT:ERB
• CIK: 1095858
• Web: www.erbadiagnostics.com
• Phone: 305-324-2300
• Fax: 305-324-2395
• Employees: 134
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A